中国癌症杂志 ›› 2015, Vol. 25 ›› Issue (12): 959-965.doi: 10.3969/j.issn.1007-3969.2015.12.007

• 论著 • 上一篇    下一篇

BTG1对喉癌细胞增殖和凋亡的影响及其机制研究

姜润学1,胡万宁1,孙国贵2,李 军1,韩晓晨1,蔡海峰1   

  1. 1.河北联合大学附属唐山市人民医院头颈外科,河北 唐山063000 ;
    2.河北联合大学附属唐山市人民医院放化疗科,河北 唐山063000
  • 出版日期:2015-12-30 发布日期:2016-02-03
  • 通信作者: 胡万宁 E-mail:rmyy_hwn@163.com

The effect of BTG1 overexpression on the proliferation and apoptosis of laryngeal cancer cells and its molecular mechanism in vitro

JIANG Runxue1, HU Wanning1, SUN Guogui2, LI Jun1, HAN Xiaochen1, CAI Haifeng1   

  1. 1.Department of Head and Neck Surgery, Tangshan People’s Hospital of Hebei United University, Tangshan 063000, Hebei Province, China; 2.Department of Chemoradiotherapy, Tangshan People’s Hospital of Hebei United University, Tangshan 063000, Hebei Province, China
  • Published:2015-12-30 Online:2016-02-03
  • Contact: HU Wanning E-mail: rmyy_hwn@163.com

摘要: 背景与目的:在多种细胞中B细胞易位基因1(B-cell translocation gene 1,BTG1)能够抑制细胞增殖,促进细胞凋亡,调节细胞周期进程及分化。该研究通过体外实验探讨BTG1高表达对喉癌Hep-2细胞增殖、凋亡及细胞周期的影响及其相关作用机制。方法:构建pEGFP-N1-BTG1,培养并转染喉癌Hep-2细胞,分为实验组(转染pEGFP-N1-BTG1的Hep-2细胞)和对照组(转染pEGFP-N1空质粒的Hep-2细胞)。采用蛋白[质]印迹法(Western blot)检测两组细胞中BTG1蛋白的表达水平;应用MTT法检测细胞的增值活性;使用流式细胞术检测细胞周期分布和磷脂酰丝氨酸外翻分析(Annexin Ⅴ-FITC/PI)检测细胞凋亡;采用Western blot法检测细胞周期调控蛋白Cyclin D1、凋亡相关蛋白Bcl-2表达情况。结果:成功构建pEGFP-N1-BTG1,Western blot检测结果显示,实验组细胞中BTG1蛋白表达水平明显高于对照组细胞(0.921±0.091 vs 0.308±0.047,P<0.05)。实验组与对照组细胞相比,从第24 h实验组细胞生长速度减慢,细胞增值能力降低,两组比较差异有统计学意义(P<0.05);实验组细胞中Cyclin D1蛋白表达水平下降(0.436±0.023 vs 0.916±0.092,P<0.05),细胞周期的G0/G1期细胞比例升高[(85.1±5.2)% vs (63.8±3.1)%,P<0.05)];S期细胞比例降低[(8.3±1.1)% vs(23.1±1.5)%,P<0.05];实验组细胞Annexin Ⅴ增多,细胞早期凋亡率升高[(10.3±1.1)% vs (2.8±0.3)%,P<0.05],抗凋亡蛋白Bcl-2表达水平降低(0.167±0.009 vs 0.834±0.084,P<0.05)。结论:BTG1高表达能明显抑制喉癌Hep-2细胞的生长增殖、诱导凋亡,其可能的机制与BTG1参与细胞周期调控、诱导细胞凋亡相关。

关键词: 喉癌, BTG1, 增殖, 凋亡, 细胞周期

Abstract: Background and purpose: B-cell translocation gene 1(BTG1) can inhibit cell proliferation, promote cell apoptosis and regulate cell cycle progression and differentiation in a variety of cell types. This study aimed to explore the influence on cell proliferation, apoptosis and cell cycle and its related mechanism of laryngeal cancer Hep - 2 cell lines through BTG1 overexpression by in vitro experiments. Methods: The BTG1 expression plasmids were constructed and transfected into Hep-2. They were divided into experimental group (transfected BTG1 of Hep-2 cells) and control group (transfected empty plasmid of Hep-2 cells). Western blot method was used to identify BTG1 protein expression levels of cells; proliferation activity of cells was detected by MTT assay; flow cytometry was used to analyze the cell cycle distribution and Annexin Ⅴ-FITC/PI cell apoptosis; Western blot was also used to assay cell cycle regulatory protein and apoptosis-related protein expression. Results: The pEGFP-N1-BTG1 plasmid was constructed successfully, and the expression of BTG1 protein was higher in experimental group than that in control group (0.921±0.091 vs 0.308±0.047, P<0.05). Compared with the two group of laryngeal cancer Hep-2 cells, the cell growth in experimental group was slowed down and the proliferation was reduced (P<0.05); Cyclin D1 protein expression level was decreased (0.436±0.023 vs 0.916±0.092, P<0.05), the proportion of G0/G1 phase cell cycle was increased [(85.1±5.2)% vs (63.8±3.1)%, P<0.05], the proportion of S phase cell was decreased [(8.3±1.1)% vs (23.1±1.5)%, P<0.05], phosphatidylserine ectropion in experimental group was increased, cell early apoptosis was significant [(10.3±1.1)% vs (2.8±0.3)%, P<0.05] and anti-apoptotic protein Bcl-2 expression level was reduced(0.167±0.009 vs 0.834±0.084, P<0.05). Conclusion: BTG1 high expression could inhibit the proliferation growth of laryngeal Hep-2 cells and promote its apoptosis, and the possible mechanisms are interrelated with BTG1 involved in cell cycle regulation and causing cell apoptosis.

Key words: Laryngeal cancer, BTG1, Proliferation, Apoptosis, Cell cycle